Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus

NCT03052400 is registered in ClinicalTrials.gov with Charles Drew University of Medicine and Science as lead sponsor.

NCT NCT03052400
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03052400 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Mifepristone in Males With Type 2 Diabetes Mellitus
Lead sponsor
Charles Drew University of Medicine and Science
Phase
Phase 2
Overall status
Terminated
Start date
February 3, 2017
Completion date
May 31, 2021
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insulin resistance, type 2 diabetes mellitus